IBDEI0Q0 ; ; 01-FEB-2022
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,11691,2)
 ;;=^5015600
 ;;^UTILITY(U,$J,358.3,11692,0)
 ;;=N10.^^46^572^6
 ;;^UTILITY(U,$J,358.3,11692,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11692,1,3,0)
 ;;=3^Acute Tubulo-Interstitial Nephritis
 ;;^UTILITY(U,$J,358.3,11692,1,4,0)
 ;;=4^N10.
 ;;^UTILITY(U,$J,358.3,11692,2)
 ;;=^5015570
 ;;^UTILITY(U,$J,358.3,11693,0)
 ;;=N17.8^^46^572^4
 ;;^UTILITY(U,$J,358.3,11693,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11693,1,3,0)
 ;;=3^AKI,Other
 ;;^UTILITY(U,$J,358.3,11693,1,4,0)
 ;;=4^N17.8
 ;;^UTILITY(U,$J,358.3,11693,2)
 ;;=^5015601
 ;;^UTILITY(U,$J,358.3,11694,0)
 ;;=N17.9^^46^572^5
 ;;^UTILITY(U,$J,358.3,11694,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11694,1,3,0)
 ;;=3^AKI,Unspec
 ;;^UTILITY(U,$J,358.3,11694,1,4,0)
 ;;=4^N17.9
 ;;^UTILITY(U,$J,358.3,11694,2)
 ;;=^338532
 ;;^UTILITY(U,$J,358.3,11695,0)
 ;;=R39.2^^46^572^15
 ;;^UTILITY(U,$J,358.3,11695,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11695,1,3,0)
 ;;=3^Pre-Renal Uremia
 ;;^UTILITY(U,$J,358.3,11695,1,4,0)
 ;;=4^R39.2
 ;;^UTILITY(U,$J,358.3,11695,2)
 ;;=^5019348
 ;;^UTILITY(U,$J,358.3,11696,0)
 ;;=N13.9^^46^572^14
 ;;^UTILITY(U,$J,358.3,11696,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11696,1,3,0)
 ;;=3^Obstructive and Reflux Uropathy,Unspec
 ;;^UTILITY(U,$J,358.3,11696,1,4,0)
 ;;=4^N13.9
 ;;^UTILITY(U,$J,358.3,11696,2)
 ;;=^5015589
 ;;^UTILITY(U,$J,358.3,11697,0)
 ;;=N13.1^^46^572^11
 ;;^UTILITY(U,$J,358.3,11697,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11697,1,3,0)
 ;;=3^Hydronephrosis w/ Ureteral Stricture NEC
 ;;^UTILITY(U,$J,358.3,11697,1,4,0)
 ;;=4^N13.1
 ;;^UTILITY(U,$J,358.3,11697,2)
 ;;=^5015576
 ;;^UTILITY(U,$J,358.3,11698,0)
 ;;=N13.2^^46^572^10
 ;;^UTILITY(U,$J,358.3,11698,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11698,1,3,0)
 ;;=3^Hydronephrosis w/ Renal and Ureteral Calculous Obstruction
 ;;^UTILITY(U,$J,358.3,11698,1,4,0)
 ;;=4^N13.2
 ;;^UTILITY(U,$J,358.3,11698,2)
 ;;=^5015577
 ;;^UTILITY(U,$J,358.3,11699,0)
 ;;=N13.30^^46^572^13
 ;;^UTILITY(U,$J,358.3,11699,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11699,1,3,0)
 ;;=3^Hydronephrosis,Unspec
 ;;^UTILITY(U,$J,358.3,11699,1,4,0)
 ;;=4^N13.30
 ;;^UTILITY(U,$J,358.3,11699,2)
 ;;=^5015578
 ;;^UTILITY(U,$J,358.3,11700,0)
 ;;=N13.39^^46^572^12
 ;;^UTILITY(U,$J,358.3,11700,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11700,1,3,0)
 ;;=3^Hydronephrosis,Other
 ;;^UTILITY(U,$J,358.3,11700,1,4,0)
 ;;=4^N13.39
 ;;^UTILITY(U,$J,358.3,11700,2)
 ;;=^5015579
 ;;^UTILITY(U,$J,358.3,11701,0)
 ;;=R33.9^^46^572^16
 ;;^UTILITY(U,$J,358.3,11701,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11701,1,3,0)
 ;;=3^Urinary Retention,Unspec
 ;;^UTILITY(U,$J,358.3,11701,1,4,0)
 ;;=4^R33.9
 ;;^UTILITY(U,$J,358.3,11701,2)
 ;;=^5019332
 ;;^UTILITY(U,$J,358.3,11702,0)
 ;;=I75.81^^46^572^8
 ;;^UTILITY(U,$J,358.3,11702,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11702,1,3,0)
 ;;=3^Atheroembolism of Kidney
 ;;^UTILITY(U,$J,358.3,11702,1,4,0)
 ;;=4^I75.81
 ;;^UTILITY(U,$J,358.3,11702,2)
 ;;=^328516
 ;;^UTILITY(U,$J,358.3,11703,0)
 ;;=R34.^^46^572^7
 ;;^UTILITY(U,$J,358.3,11703,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11703,1,3,0)
 ;;=3^Anuria and Oliguria
 ;;^UTILITY(U,$J,358.3,11703,1,4,0)
 ;;=4^R34.
 ;;^UTILITY(U,$J,358.3,11703,2)
 ;;=^5019333
 ;;^UTILITY(U,$J,358.3,11704,0)
 ;;=K76.7^^46^572^9
 ;;^UTILITY(U,$J,358.3,11704,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,11704,1,3,0)
 ;;=3^Hepatorenal Syndrome
